26Jun 2017

A COMBINED EFFICACY OF KAISHORE GUGGULU AND PUNARNAVADI GUGGULU IN THE MANAGEMENT OF VATARAKTA (GOUT): A CASE SERIES.

  • Research Officer (Ayu), Regional Ayurveda Research Institute for Nutritional Disorders, CCRAS, Ministry of AYUSH, Govt. of India, Mandi H.P.
  • Assistant Director & Incharge, Regional Ayurveda Research Institute for Nutritional Disorders, CCRAS, Ministry of AYUSH, Govt. of India, Mandi H.P.
  • Director General, Central Council for Research in Ayurvedic Sciences (CCRAS), Janakpuri, New Delhi.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Even though Gout is generally grouped under Arthritis, it is a metabolic disorder of Uric Acid. Extensive description of Vatarakta in ayurvedic classics shows that it was prevalent widely in that era too. In present era changes in lifestyle & food habits leads to recognizable increase in incidence of Vatarakta in common people. Total 35 patients of Vatarakta (Gout), out of which 32 patients completed the course of treatment. Study was Open label, Interventional, Prospective and Single arm clinical trial for the duration of 42 days (6 weeks). Patients were given Kaishore Guggulu and Punarnavadi Guggulu 2 tablets (500 mg) each twice a day with lukewarm water. The required amount of medicines was supplied by the IMPCL (A Govt. of India Enterprise) Mohan ? Dist. Almora, Uttrakhand after ensuring safety and quality batch to batch. Patients were followed 2-week interval i.e. on 2nd,4th and 6thweek of treatment period. The effects of treatment on subjective and objective parameter evaluated. Results obtained shows encouraging results in the management of Vatarakta (Gout) with no side effects observed so far.

  1. Charak Samhita, Editor Pt. Kashinath Shastri & Gorakhnath Chaturvedi, Ch.Chi. 29/11 Chaukhambha Bharti Academy, Varanasi, 2001; 2: 820.
  2. Burns C, Wortmann RL. Burns C, Wortmann R.L. Burns, Christopher, and Robert L. Wortmann.Chapter 44. Gout. In: Imboden JB, Hellmann DB, Stone JH. Imboden J.B., Hellmann D.B., Stone J.H. Eds. John B. Imboden, et al.eds. CURRENT Rheumatology Diagnosis & Treatment, 3e. New York, NY: McGraw-Hill; 2013. http://accessmedicine.mhmedical.com/content.aspx?bookid=506&Sectionid=42584931. Accessed April?2, 2015.
  3. Neogi T. Gout.?N Engl J Med2011; 364:443-452.
  4. Krishnan E. Chronic kidney disease and the risk of incident gout among middle-aged men.?Arthritis Rheum. 2013;65(12):3271?3278.
  5. Longo, Fauci, Kasper, Hausear, Jameson, Loscalzo.2012, Harrison?s Principles of Internal Medicine, Chap 333, 8e, The McGraw Hill Cpmpanies, USA.
  6. Ayurveda and Gout 2017,27/03/2017, http://ayurvedic-herbalist.com/ayurveda-and-gout/
  7. Singh,J2015,Ayurtimes,27-03-2017,https://www.ayurtimes.com/kaishore-guggulu/
  8. Shishodia S, Aggarwal BB. Guggulsterone inhibits NF ?kappa B and Ikappa Balpha kinase activation, suppressesexpression of anti-apoptopic genes products and enhance apoptosis. J Biol. Chem. 2004; 279(45): 47148-47158.
  9. Thapa DM, Dongra J. Nodulocystic acne oral guggulipid versus tetracycline. J Dermatol 1994; 21: 729.
  10. Jana U, Chattopadhyay RN, Shw BP. Preliminary studies on anti-inflammaory activity of Zingiber officinale Rosc., Vitex negundo Linn. and Tinospora cordifolia (Willid) Miers in albino rats. Indian J Pharm 1999; 31: 232-233.
  11. Sharma AK, Singh RH. Screening of anti inflammatory activity of certain indigenous drugs on carragenin induced hind paw oedema in rats. Bull Medico Ethenobot Res. 1980; 1(2): 12.
  12. Raji Y, Udoh US, Oluwadara OO, Akinsomisoye OS, Awobajo O, Adeshoga K. Anti-inflammatory and analgesic properties of the rhizome extract of Zingiber Officinale. African Journal of Biomedical Res. 2002; 5: 121 -124.
  13. Bhande RM, Laakshmayya KP, Mahurkar NK, Setty SR. Pharmacological screening of root of Operculina turpethum and its formulations. Acta Pharmaceutica Sciencia 2006; 48: 11-17.
  14. Sharma SK. Perianayagam BJ, Joseph A, Christina AJM. Antiinflamatory activity of ethanol an aqueous extracts of Emblica officinalis Geartn fruits. Hamdard Medicus 2003; 46: 75-78.
  15. Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six Rasayana Hebrs used in Ayurvedic medicines. Phytotherapy Res. 1999; 13: 275-291.
  16. Jeena KL, Joy KL, Kuttan R. Effects of Emblica officinalis, Phyllanthus amarus and Picrorhiza kurroa on N-nitrosodiethyl amine induced hepatocarcinogenesis. Cancer Lett. 1999; 136: 11-16.
  17. Jose KJ, Kuttan R. Hepatoprotective activity of Emblica officinalis and Chyavanprash. Journal of Ethnopharmacology 2000; 72(1-2): 135-140. \
  18. Jadona A, Bhadauriaa M, Shukla S. Protective effect of Terminalia belerica and gallic acid against carbon tetrachloride induced damage in albino rats. Journal of Ethnopharmacology 2007; 109(2): 214-218.
  19. Wadekar RR, Agarwal SV, Tewari KM, Shinde RD, Mate S, Patil KS, Effect of Baliospermum montanum? root extract on phagocytosis by human neutrophils. International Journal of Green Pharmacy 2008; 2: 46-49.
  20. Sunila ES, Kuttan G. Immunomodulatory and antitumor activities of Piper longum Linn. and piperine. J Ethanopharmacol 2004; 90(2-3): 339-346.

[Vikas Nariyal, Om Raj Sharma and K.S. Dhiman. (2017); A COMBINED EFFICACY OF KAISHORE GUGGULU AND PUNARNAVADI GUGGULU IN THE MANAGEMENT OF VATARAKTA (GOUT): A CASE SERIES. Int. J. of Adv. Res. 5 (Jun). 1793-1798] (ISSN 2320-5407). www.journalijar.com

DR VIKAS NARIYAL
CCRAS

DOI:

Article DOI: 10.21474/IJAR01/4605      
DOI URL: http://dx.doi.org/10.21474/IJAR01/4605

Download Full Paper

Download PDF No. of Downloads: 371 | No. of Views: 2512